# Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

> **NCT03852459** · PHASE2 · COMPLETED · sponsor: **Aponia Laboratories, Inc.** · enrollment: 251 (actual)

## Conditions studied

- Pain, Acute

## Interventions

- **DRUG:** S-Ibuprofen
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03852459
- **Lead sponsor:** Aponia Laboratories, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-12
- **Primary completion:** 2019-04-04
- **Final completion:** 2019-04-11
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2022-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03852459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03852459, "Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03852459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*